TIFFANY GRAY: Open Payments
NPI 1477034601 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 21 payments from 13 companies in 2025. Trend: 2023 $1,487 · 2024 $1,236 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Kite Pharma, Inc. | 1 | $26 |
| Biogen, Inc. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: OPDIVO, Xtandi, FRUZAQLA, LUTATHERA, Yescarta, ELAHERE, ZURZUVAE, MYRISK.
Industry payments across FL — which companies pay providers there.
